Trial: 202001226

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Phase

II

Principal Investigator

Pedersen, Katrina

Disease Site

Small Intestine

Learn more about this study at: clinicaltrials.gov